Get 20% lifetime commission for referring investors to digrin.com
here.
Glass House Brands Inc. (GHBWF) Financials
Stock symbol GHBWF is outdated, potentially delisted? Maybe it is available on other exchange?
GHBWF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 326.4 million | 148.4 million |
| Dec. 31, 2025 | 318.0 million | 143.7 million |
| Sept. 30, 2025 | 319.8 million | 215.6 million |
| June 30, 2025 | 334.6 million | 142.2 million |
GHBWF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -15.1 million | ? |
| Dec. 31, 2025 | -6.2 million | 4.3 million |
| Sept. 30, 2025 | -13.7 million | 4.1 million |
| June 30, 2025 | 8.3 million | 2.9 million |
GHBWF Net Income
No data available :(
GHBWF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 24.5 million | 68.0 million | 3.9 million |
| Dec. 31, 2025 | 19.8 million | 68.5 million | 3.9 million |
| Sept. 30, 2025 | 26.3 million | 68.8 million | 6.4 million |
| June 30, 2025 | 40.7 million | 65.8 million | 6.9 million |
GHBWF Shares Outstanding
GHBWF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 3.5 million | - | 20.1 million | - |
| Dec. 31, 2025 | 2.4 million | - | 21.9 million | 476000 |
| Sept. 30, 2025 | 8.6 million | - | 19.1 million | 703000 |
| June 30, 2025 | 9.5 million | - | 17.4 million | 803000 |
GHBWF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 40.0 million | 34.0 million |
| Dec. 31, 2025 | 39.5 million | 30.1 million |
| Sept. 30, 2025 | 38.4 million | 26.7 million |
| June 30, 2025 | 59.9 million | 27.9 million |
GHBWF
Price: $0.13
52 week price:
Payout Ratio Range:
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 10.7 million
Years Paying Dividends: 1